Skip to content
TickerMagic

Aster DM Healthcare Limited

ASTERDMNSEHealthcare
₹739.3
+8.30 (+1.14%) · EOD 2026-11-20

Our verdict

Hold

Financial trend (88/100) does the heavy lifting; valuation (3/100) is the drag.

ExpensiveHealth AOvervalued
Quality 55Momentum 60Value 3Trend 88The Spark ↓

Our fair value

Overvalued by 42%
₹432.12down 41.55%
Price ₹739Range ₹370 – ₹594

Buy-below (20% margin of safety): ₹345.7

The bottom line

Aster DM Healthcare Limited earns a Hold from TickerMagic, with a blended score of 45/100. On 119.7x trailing earnings it sits pricier than the Healthcare median of about 37.4x. The price is about 15% below its 52-week high of ₹869.7 and 38% above the low of ₹535.6. Financial health scores 100/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 5/9. The average analyst target of ₹795.27 implies about 8% upside across 11 analysts. It clears 8 of 13 investability checks, with durability 55, valuation 6 and momentum 60 on our 0–100 scales.

Analysis by Ankit Sharma · TickerMagic's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.

Intrinsic value
Our fair value
₹432.12down 41.55%
Overvalued by 42%
Price ₹739.3Range ₹369.65–₹594.23
DCF + relative blendhigh confidence

With a 20% margin of safety, our buy-below price is ₹345.7.

Analyst views

11 analysts11 buy · 0 hold · 0 sell
12-month consensus target₹795.27up 7.57%

1-year price

EOD · 2026-11-20
1D
up 1.14%
1W
up 0.46%
1M
up 10.81%
3M
down 9.62%
6M
down 1.28%
1Y
—

52-week range

-14.99% from the 52-week high.

Trend check
Above 50-DMA₹715Above 200-DMA₹722

Price above both moving averages reads as an intact uptrend; below both, the trend is against you.

Verdict pillars

Hold45
A
Financial health 100/100
Altman Z 8.94 · Safe zone

Piotroski F-score 5/9 — quality of earnings & balance sheet.

Our scores

Durability55
Valuation6
Momentum60

Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.

Investability checklist

Passed 8 of 13 checks
Each check screens one fundamentals, valuation or trend signal.
  • Fail: ROE above 15%: 10.1%
  • Pass: Low debt (D/E < 0.5): 0.46x
  • Pass: Positive free cash flow
  • Pass: Revenue growth > 10%: 18%
  • Pass: Earnings growing: 72%
  • Fail: Net margin ≥ 10%: 8.4%
  • Pass: Current ratio > 1.5: 1.99
  • Fail: Below our fair value
  • Fail: Margin of safety ≥ 20%
  • Pass: Above 200-day average
  • Pass: Above 50-day average
  • No data: Positive 1-year return
  • Pass: Altman Z in safe zone: Z 8.94
  • Fail: Piotroski ≥ 7: 5/9

Quarterly results

Revenue · 1Q2026
₹1,182 Cr
Net profit
₹140 Cr
Margin
12%
2Q2025
3Q2025
4Q2025
1Q2026
Revenue Net profitLatest revenue QoQ -0%

Annual financials

Revenue · 2026
₹4,643 Cr
Net profit
₹364 Cr
Margin
8%
2023
2024
2025
2026
Revenue Net profitLatest revenue YoY +12%

Shareholding

  • Promoter53.3%
  • Institutions34.3%
  • Public & other12.4%

Promoter holding via insider stake; institutional via reported holdings.

Key fundamentals

Market cap
₹39,789 Cr
P/E ratio
119.7
P/B ratio
8.67
EPS (TTM)
₹6.43
ROE
10.1%
Debt / Equity
0.46x
Profit margin
8.4%
Free cash flow
₹1,347 Cr
52-week high
₹869.7
-14.99% from high
52-week low
₹535.6
Dividend yield
0.5%
Beta
-0.03
SWOT snapshot

Bull case vs bear case

Bull case

Strengths

  • Financially solid — Altman Z 8.94.

Opportunities

  • Earnings growing (72% YoY).
  • Revenue growing (18% YoY).

Bear case

Threats

  • Rich valuation versus sector peers.
  • Trades ~42% above our estimated fair value.

About Aster DM Healthcare Limited

Aster DM Healthcare operates a network of hospitals and clinics across India, supported by in-house and wholesale pharmacies. The company's business segments include hospital operations, clinic services, wholesale pharmacy distribution, and other healthcare services. It maintains pharmacies at its hospital and clinic facilities to serve patient needs.

Aster DM Healthcare Limited — frequently asked questions

Is Aster DM Healthcare Limited a buy, hold or sell?

TickerMagic currently rates Aster DM Healthcare Limited (ASTERDM) a Hold, based on a blended score of 45/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.

What is Aster DM Healthcare Limited's fair value?

Our blended DCF and relative-valuation model estimates Aster DM Healthcare Limited's fair value at about ₹432.12, versus a current price of ₹739.3 — roughly 42% downside. On that basis the stock looks overvalued by 42%.

Is Aster DM Healthcare Limited financially healthy?

Aster DM Healthcare Limited scores 100/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 5/9.

How has Aster DM Healthcare Limited's share price performed?

Aster DM Healthcare Limited is down 10% over three months, and last traded at ₹739.3. Past performance doesn't predict future returns.

Our verdict, fair value, financial-health and checklist are TickerMagic's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.